Cantheon Capital Overview
- Investor Type
-
PE/Buyout
- Status
-
Inactive
- Investments
-
3
- Portfolio
-
1
- Exits
-
2
Cantheon Capital General Information
Company Description
Cantheon Capital was a private equity firm based in Dallas, Texas. The firm sought to invest through means of convertible debt, debt, and growth capital. The firm preferred to invest in biotechnology sectors.
Business Details
Website
www.cantheoncapital.comInvestor Status
Primary Investor Type
Other Investor Types
Corporate Office
- 4925 Greenville Avenue
- Dallas, TX 75206
- United States
Cantheon Capital Investments (3)
Cantheon Capital’s most recent investment was a with Avata Biosciences for . The deal was made on 07-Mar-2024.
| Company Name | Deal Date | Deal Type | Deal Size | Industry | Company Stage | Lead Partner |
|---|---|---|---|---|---|---|
| Avata Biosciences | 07-Mar-2024 | Drug Discovery | Clinical Trials - Phase 1 | |||
| Psycheceutical | 01-Jul-2023 | Drug Discovery | Clinical Trials - Phase 1 | |||
| Zelira HOPE 1 SPV | 01-Feb-2023 | PE Growth/Expansion | Pharmaceuticals | Generating Revenue |
Cantheon Capital Exits (2)
Cantheon Capital has made a total of 2 exits. Its latest exit was from Avata Biosciences. The exit was categorized as .
| Company Name | Exit Date | Exit Type | Exit Size |
|---|---|---|---|
| Avata Biosciences | |||
| Psycheceutical | Secondary Transaction - Private |
Cantheon Capital Investments by Industry, Year, and Region
Cantheon Capital FAQs
-
What is Cantheon Capital?
Cantheon Capital was a private equity firm based in Dallas, Texas.
-
Where is Cantheon Capital headquartered?
Cantheon Capital is headquartered in Dallas, TX.
-
How many investments has Cantheon Capital made?
Cantheon Capital has made 3 investments.
-
What has Cantheon Capital invested in?
Cantheon Capital has made numerous investments in companies like Avata Biosciences, Psycheceutical, and Zelira HOPE 1 SPV within the Drug Discovery and Pharmaceuticals industries.
-
What has Cantheon Capital invested in recently?
Cantheon Capital's latest investment was on 07-Mar-2024 in Avata Biosciences, a company within the Drug Discovery industry.
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read more -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process